Panic attacks are acute periods of intense fear or terror that occur suddenly. Panic attacks are characterized by symptoms like shortness of breath, dizziness, rapid heartbeat, trembling or shaking, and fears of fainting, choking, or losing control. Digital therapeutics are helping millions of people manage their panic attacks by providing convenient smartphone-based treatment options. These apps use cognitive behavioral therapy (CBT) techniques, relaxation exercises, emergency coping strategies to stop panic attacks.
The global Panic Attack Treatment Market is estimated to be valued at US$ 2.4 billion in 2023 and is expected to exhibit a CAGR of 16.8%over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Rapid Adoption of Digital Therapeutics: Digital therapeutics are gaining rapid adoption driven by their affordability, accessibility, and flexibility compared to traditional therapy options for panic attack treatment. These app-based solutions empower users to access evidence-based CBT programs from the convenience of their smartphones. The anonymity offered by digital platforms also encourages more individuals to seek help for panic attacks without stigma. As internet and smartphone penetration continues to increase globally, the digital therapeutics segment is expected to witness strong growth over the forecast period led by the trends of telehealth and remote patient monitoring gaining centerstage post-COVID.
Segment Analysis
The global panic attack treatment market is segmented based on treatment and distribution channel. The drugs segment dominates the market owing to high reliance on drugs for the treatment of panic attacks. Drugs like antidepressants and anxiolytics are widely used to reduce symptoms. Within drugs, SSRIs have the highest demand as they are preferred as the first line of treatment for panic disorder.
Key Takeaways
The Global Panic Attack Treatment Market Demand is expected to witness high growth.
Regional analysis: The North American region currently dominates the global panic attack treatment market due to high awareness about mental health issues and availability of advanced treatment options. Presence of major market players and availability of reimbursement for panic disorder treatment fuels the market growth in the region.
Key players operating in the Panic Attack Treatment market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca, GlaxoSmithKline plc., Eli Lilly and Company, Bristol-Myers Squibb Company.
Explore more information on this topic, Please visit-
https://www.marketwebjournal.com/global-panic-attack-treatment-market-growth-and-trnds-analysis-share-size-demand-forecast/
Explore more trending article related this topic:
https://lotstoexpress.com/decoding-life-navigating-health-landscape-with-genomic-biomarkers-as-compass-points/
Comments
0 comment